EUVIMEDEUVIMED entdecken
Crossref

In Situ Bioconjugation of a Maleimide-Functionalized Ruthenium-Based Photosensitizer to Albumin for Photodynamic Therapy

Robin Vinck, Orsolya Dömötör, Johannes Karges iD, Marta Jakubaszek, Johanne Seguin iD, Mickaël Tharaud iD, Vincent Guérineau, Kevin Cariou, Nathalie Mignet, Éva A Enyedy iD, Gilles Gasser iD

Inorganic Chemistry · 2023

DOI: 10.1021/acs.inorgchem.3c01984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2023. Verfasst von Robin Vinck und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, F-75005 Paris, France. Hauptthemen laut MEDLINE: Ruthenium, Photochemotherapy, Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, E?tv?s Lor?nd Research Network, Magyar Tudom?nyos Akad?mia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maleimide-containing prodrugs can quickly and selectively react with circulating serum albumin following their injection in the bloodstream. The drug-albumin complex then benefits from longer blood circulation times and better tumor accumulation. Herein, we have applied this strategy to a previously reported highly phototoxic Ru polypyridyl complex-based photosensitizer to increase its accumulation at the tumor, reduce off-target cytotoxicity, and therefore improve its pharmacological profile. Specifically, two complexes were synthesized bearing a maleimide group: one complex with the maleimide directly incorporated into the bipyridyl ligand, and the other has a hydrophilic linker between the ligand and the maleimide group. Their interaction with albumin was studied in-depth, revealing their ability to efficiently bind both covalently and noncovalently to the plasma protein. A crucial finding is that the maleimide-functionalized complexes exhibited significantly lower cytotoxicity in noncancerous cells under dark conditions compared to the nonfunctionalized complex, which is a highly desirable property for a photosensitizer. The binding to albumin also led to a decrease in the phototoxicity of the Ru bioconjugates in comparison to the nonfunctionalized complex, probably due to a decreased cellular uptake. Unfortunately, this decrease in phototoxicity was not compensated by a dramatic increase in tumor accumulation, as was demonstrated in a tumor-bearing mouse model using inductively coupled plasma mass spectrometry (ICP-MS) studies. Consequently, this study provides valuable insight into the future design of in situ albumin-binding complexes for photodynamic therapy in order to maximize their effectiveness and realize their full potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RutheniumPhotochemotherapyNeoplasmsCoordination ComplexesAntineoplastic AgentsAnimalsMicePhotosensitizing AgentsLigandsSerum AlbuminMaleimides

Substanzen

Photosensitizing AgentsRutheniumLigandsSerum AlbuminMaleimidesCoordination ComplexesAntineoplastic Agents

Autor:innen und Institutionen

  • Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, F-75005 Paris, France.
  • MTA-SZTE Lendület Functional Metal Complexes Research Group, Department of Molecular and Analytical Chemistry, University of Szeged, Dóm tér 7. H-6720 Szeged, Hungary.
  • Université Paris Cité, UTCBS, INSERM, CNRS, 75006 Paris, France.
  • Biogéochimie à l'Anthropocène des Eléments et Contaminants Emergents, Institut de Physique du Globe de Paris, 75005 Paris, France.
  • Institut de Chimie des Substances Naturelles, CNRS UPR2301, Université Paris-Sud, Université Paris-Saclay, Avenue de la Terrasse, 91198 Gif-sur-Yvette Cedex, France.

ORCID-Profile: Johannes Karges, Johanne Seguin, Mickaël Tharaud, Éva A Enyedy, Gilles Gasser

Förderung

  • Agence Nationale de la Recherche
  • E?tv?s Lor?nd Research Network
  • Magyar Tudom?nyos Akad?mia
  • Nemzeti Kutat?si Fejleszt?si ?s Innov?ci?s Hivatal
  • H2020 European Research Council

Zitieren

APA

Vinck, R., Dömötör, O., Karges, J., Jakubaszek, M., Seguin, J., Tharaud, M., Guérineau, V., Cariou, K., Mignet, N., Enyedy, É. A., & Gasser, G. (2023). In Situ Bioconjugation of a Maleimide-Functionalized Ruthenium-Based Photosensitizer to Albumin for Photodynamic Therapy. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.3c01984

Vancouver

Vinck R, Dömötör O, Karges J, Jakubaszek M, Seguin J, Tharaud M, et al. In Situ Bioconjugation of a Maleimide-Functionalized Ruthenium-Based Photosensitizer to Albumin for Photodynamic Therapy. Inorganic Chemistry. 2023. doi:10.1021/acs.inorgchem.3c01984

BibTeX
@article{Vinck2023,
  author = {Vinck, Robin and Dömötör, Orsolya and Karges, Johannes and Jakubaszek, Marta and Seguin, Johanne and Tharaud, Mickaël and Guérineau, Vincent and Cariou, Kevin and Mignet, Nathalie and Enyedy, Éva A and Gasser, Gilles},
  title = {In Situ Bioconjugation of a Maleimide-Functionalized Ruthenium-Based Photosensitizer to Albumin for Photodynamic Therapy},
  journal = {Inorganic Chemistry},
  year = {2023},
  doi = {10.1021/acs.inorgchem.3c01984}
}
Kostenlos starten →